Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer

NCT02713529 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

117

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer

Interventions

BIOLOGICAL: AMG820 and pembrolizumab

Sponsor

AmMax Bio, Inc.

Collaborators

[object Object]